310 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With High-grade Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
9 Not yet recruiting Postoperative Quality of Recovery After Transurethral Resection of the Bladder
Conditions: Urinary Bladder Neoplasms;   Transurethral Resection of the Bladder;   Postoperative Recovery
Interventions: Procedure: Spinal anesthesia;   Procedure: General anesthesia;   Drug: bupivacaine;   Drug: fentanyl;   Drug: propofol;   Drug: sevoflurane
10 Not yet recruiting Study of Tremelimumab in Patients With Advanced Solid Tumors
Condition: UBC (Urothelial Bladder Cancer)/ TNBC (Triple-negative Breast Cancer)/ PDAC (Pancreatic Ductal Adenocarcinoma)
Interventions: Biological: Tremelimumab monotherapy;   Biological: MEDI4736 monotherapy;   Biological: MEDI4736 + tremelimumab combination therapy
11 Not yet recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 5 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
Conditions: Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: mirabegron
12 Not yet recruiting The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
Condition: Overactive Bladder
Intervention: Drug: conjugated estrogen
13 Recruiting Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Conditions: Interstitial Cystitis;   Painful Bladder Syndrome
Interventions: Drug: Lidocaine;   Drug: Placebo
14 Not yet recruiting Study of MEDI4736 With or Without Tremelimumab Versus Standard of Care Chemotherapy in Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Gemcitabine
15 Recruiting Trans-MAPP Symptom Patterns Study (SPS)
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
16 Not yet recruiting A Trial of Transcutaneous Nerve Stimulation for OAB
Condition: Overactive Bladder
Interventions: Other: Transcutaneous tibial nerve stimulation;   Other: Sham transcutaneous tibial nerve stimulation
17 Recruiting Overactive Bladder Education
Conditions: Urinary Bladder, Overactive;   Urinary Incontinence, Urge
Intervention: Other: Overactive Bladder Care Plan counseling
18 Recruiting The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
Conditions: Overactive Bladder;   Pelvic Organ Prolapse
Intervention:
19 Recruiting Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.
Condition: Urinary Bladder, Neurogenic
Interventions: Drug: Fesoterodine PR 4 mg;   Drug: Fesoterodine PR 8 mg;   Drug: Fesoterodine BIC 2 mg;   Drug: Fesoterodine BIC 4 mg
20 Not yet recruiting Testing the PD-1 Inhibitor Pembrolizumab After Initial Chemotherapy in Patients With Metastatic Bladder Cancer
Conditions: Urothelial Cancer;   Bladder Cancer
Interventions: Other: Placebo;   Drug: Pembrolizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years